Surgical resection for hepatocellular carcinoma: Clinical outcomes and safety in elderly patients

European Journal of Gastroenterology and Hepatology

Volumn 25, Issue 8, 2013, Pages 912-919

  Nishikawa, Hiroki ^a   Arimoto, Akira ^a   Wakasa, Tomoko ^a   Kita, Ryuichi ^a   Kimura, Toru ^a   Osaki, Yukio ^a  

^a OSAKA RED CROSS HOSPITAL   (Japan)

Author keywords

Clinical outcome; elderly patients; hepatocellular carcinoma; safety; surgical resection

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; BILIRUBIN;

ABSCESS; ACUTE HEART FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; ASPIRATION PNEUMONIA; BILE LEAKAGE; BILIRUBIN BLOOD LEVEL; BRAIN INFARCTION; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SAFETY; PERFORATION; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; SURVIVAL RATE; TUMOR VOLUME;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; BILIRUBIN; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEASIBILITY STUDIES; FEMALE; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MICROVESSELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SERUM ALBUMIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84879906346     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32835fa668     Document Type: Article

References (46)

1. Kudo M. Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010. Oncology 2010; 78:113-124.
2. Livraghi T, Mäkisalo H, Line PD. Treatment options in hepatocellular carcinoma today. Scand J Surg 2011; 100:22-29.
3. Allgaier HP, Deibert P, Zuber I, Olschewski M, Blum HE. Percutaneous radiofrequency interstitial thermal ablation of small hepatocellular carcinoma. Lancet 1999; 353:1676-1677.
4. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012; 142:1264-1273.
5. Zhou WP, Lai EC, Li AJ, Fu SY, Zhou JP, Pan ZY, et al. A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma. Ann Surg 2009; 249:195-202.
6. Nishikawa H, Osaki Y, Kita R, Kimura T, Inuzuka T, Takeda H, et al. Transcatheter arterial infusion chemotherapy prior to radiofrequency thermal ablation for single hepatocellular carcinoma reduces the risk of intrahepatic distant recurrence. Int J Oncol 2012; 41:903-909.
7. Hankey BF, Ries LA, Kosary CL, Feuer EJ, Merrill RM, Clegg LX, et al. Partitioning linear trends in age-adjusted rates. Cancer Causes Control 2000; 11:31-35.
8. Cho SJ, Yoon JH, Hwang SS, Lee HS. Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients? J Gastroenterol Hepatol 2007; 22:1226-1231.
9. Asahina Y, Tsuchiya K, Tamaki N, Hirayama I, Tanaka T, Sato M, et al. Effect of aging on riskfor hepatocellular carcinoma in chronic hepatitis Cvirus infection. Hepatology 2010; 52:518-527.
10. Kiyosawa K, Tanaka E. Characteristics of hepatocellular carcinoma in Japan. Oncology 2002; 62 (Suppl 1):5-7.
11. Ikai I, Arii S, Okazaki M, Okita K, Omata M, Kojiro M, et al. The Liver Cancer Study Group of Japan, Kyoto, Japan. Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. Hepatol Res 2007; 37: 676-691.
12. Fujii H, Itoh Y, Ohnishi N, Sakamoto M, Ohkawara T, Sawa Y, et al. Factors associated with the overall survival of elderly patients with hepatocellular carcinoma. World JGastroenterol 2012; 18:1926-1932.
13. Maŕin-Hargreaves G, Azoulay D, Bismuth H. Hepatocellular carcinoma: surgical indications and results. Crit Rev Oncol Hematol 2003; 47:13-27.
14. Mirici-Cappa F, Gramenzi A, Santi V, Zambruni A, Di Micoli A, Frigerio M, et al. Italian Liver Cancer Group. Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience. Gut 2010; 59:387-396.
15. Siegel AB, Lim EA, Wang S, Brubaker W, Rodriguez RD, Goyal A, et al. Diabetes, body mass index, and outcomes in hepatocellular carcinoma patients undergoing livertransplantation. Transplantation 2012; 94: 539-543.
16. Takahashi H, Mizuta T, Kawazoe S, Eguchi Y, Kawaguchi Y, Otuka T, et al. Efficacy and safety of radiofrequency ablation for elderly hepatocellular carcinoma patients. Hepatol Res 2010; 40:997-1005.
17. Yanaga K, Kanematsu T, Takenaka K, Matsumata T, Yoshida Y, Sugimachi K. Hepatic resection for hepatocellular carcinoma in elderly patients. Am J Surg 1988; 155:238-241.
18. Nomura F, Ohnishi K, Honda M, Satomura Y, Nakai T, Okuda K. Clinical features of hepatocellular carcinoma in the elderly: a study of 91 patients older than 70 years. Br J Cancer 1994; 70:690-693.
19. Poon RT, Fan ST, Lo CM, Liu CL, Ngan H, Ng IO, et al. Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management. Am J Gastroenterol 1999; 94:2460-2466.
20. Hazama H, Omagari K, Matsuo I, Masuda J, Ohba K, Sakimura K, et al. Clinical features and treatment of hepatocellular carcinoma in eight patients older than eighty years of age. Hepatogastroenterology 2001; 48:1692-1696.
21. Oishi K, Itamoto T, Kobayashi T, Oshita A, Amano H, Ohdan H, et al. Hepatectomy for hepatocellular carcinoma in elderly patients aged 75 years or more. J Gastrointest Surg 2009; 13:695-701.
22. Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, et al. Surgery for small liver cancers. Semin Surg Oncol 1993; 9:298-304.
23. Kaibori M, Ha-Kawa SK, Maehara M, Ishizaki M, Matsui K, Sawada S, et al. Usefulness of Tc-99m-GSA scintigraphy for liver surgery. Ann Nucl Med 2011; 25:593-602.
24. Bruix J, Sherman M. Practice Guidelines Committee. American Association for the Study of Liver Diseases: management of hepatocellular carcinoma. Hepatology 2005; 42:1208-1236.
25. Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer. Jpn J Surg 1989; 19:98-129.
26. Hu BS, Chen K, Tan HM, Ding XM, Tan JW. Comparison of laparoscopic versus open liver lobectomy (segmentectomy) for hepatocellular carcinoma. World J Gastroenterol 2011; 17:4725-4728.
27. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240:205-213.
28. Kondo K, Chijiiwa K, Funagayama M, Kai M, Otani K, Ohuchida J. Hepatic resection is justified for elderly patients with hepatocellular carcinoma. World J Surg 2008; 32:2223-2229.
29. Huang J, Li BK, Chen GH, Li JQ, Zhang YQ, Li GH, et al. Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy. J Gastrointest Surg 2009; 13:1627-1635.
30. Fortner JG, Lincer RM. Hepatic resection in the elderly. Ann Surg 1990; 211:141-145.
31. Yamamoto K, Takenaka K, Matsumata T, Shimada M, Itasaka H, Shirabe K, et al. Right hepatic lobectomy in elderly patients with hepatocellular carcinoma. Hepatogastroenterology 1997; 44:514-518.
32. Ezaki T, Yukaya H, Ogawa Y Evaluation of hepatic resection for hepatocellular carcinoma in the elderly. Br J Surg 1987; 74:471-473.
33. Nagasue N, Chang YC, Takemoto Y, Taniura H, Kohno H, Nakamura T. Liver resection in the aged (seventy years or older) with hepatocellular carcinoma. Surgery 1993; 113:148-154.
34. Takenaka K, Shimada M, Higashi H, Adachi E, Nishizaki T, Yanaga K, et al. Liver resection for hepatocellular carcinoma in the elderly. Arch Surg 1994; 129:846-850.
35. Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T. Criteria for safe hepatic resection. Am J Surg 1995; 169:589-594.
36. Health and Welfare Statistics Association. Life expectancy. J Health Welfare Stat 2004; 51:67-68.
37. Yu MC, Yuan JM. Environmental factors and riskfor hepatocellular carcinoma. Gastroenterology 2004; 127 (5 Suppl 1):S72-S78.
38. Namieno T, Kawata A, Sato N, Kondo Y, Uchino J. Age-related different clinicopathologic features of hepatocellular carcinoma patients. Ann Surg 1995; 221:308-314.
39. Kato Y, Nakata K, Omagari K, Furukawa R, Kusumoto Y, Mori I, et al. Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitisviruses. Cancer 1994; 74:2234-2238.
40. Dohmen K, Shigematsu H, Irie K, Ishibashi H. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients. Hepatogastroenterology 2003; 50:2022-2027.
41. Lautz HU, Selberg O, KörberJ, Bürger M, Müller MJ. Protein-calorie malnutrition in liver cirrhosis. Clin Investig 1992; 70:478-486.
42. Italian Multicentre Cooperative Project on Nutrition in Liver Cirrhosis. Nutritional status in cirrhosis. J Hepatol 1994; 21:317-335.
43. Nishikawa H, Osaki Y, Iguchi E, Koshikawa Y, Ako S, Inuzuka T, et al. The effect of long-term supplementation with branched-chain amino acid granules in patients with hepatitis c virus-related hepatocellular carcinoma after radiofrequency thermal ablation. J Clin Gastroenterol 2012 [Epub ahead of print].
44. Nishikawa H, Osaki Y, Inuzuka T, Takeda H, Nakajima J, Matsuda F, et al. Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 2012; 18:1379-1384.
45. Lim KC, Chow PK, Allen JC, Chia GS, Lim M, Cheow PC, et al. Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria. Ann Surg 2011; 254:108-113.
46. Xiong JJ, Altaf K, Javed MA, Huang W, Mukherjee R, Mai G, et al. Meta-analysis of laparoscopic versus open liver resection for hepatocellular carcinoma. World J Gastroenterol 2012; 18:6657-6668.